Xianglei Wu 1,2,3 , Romina Mastronicola 2,4 , Qian Tu 1,2 , Gilbert Charles Faure 1,2 , Marcelo De Carvalho Bittencourt 1,2* † and Gilles Dolivet 2,4 †
Abstract
Background: Despite aggressive regimens, the
clinical outcome
of head and neck squamous cell carcinoma remains poor. The[r]